Gosland M., Tsuboi C., Hoffman T., Goodin S., and Vore M. (1971). 17β-Estradiol glucuronide: An inducer of cholestasis and a physiological substrate of the multidrug resistance transporter. Cancer Res. 53: 5382-5385.
2.
Gumucio J. and Valdivieso V. (1971). Studies on the mechanisms of ethinyl estradiol impairment of bile flow and bile salt excretion in the rat. Gastroenterology61: 339-344.
3.
Kanai N., Lu R., Bao Y., Wolkoff AW, Vore M., and Schuster VL (in press). Estradiol 17-β D-glucuronide is a high-affinity substrate for the organic anion transporter "oatp."Am. J. Physiol.
4.
Kreek MJ (1987). Female sex steroids and cholestasis. Semin. Liver Dis. 7: 8-23.
5.
Liu Y., Hoffman T., Gosland M., and Vore M. (1995). Daunorubicin protects against estradiol-17-β-glucuronide-induced cholestasis and inhibits ATP-dependent estradiol-17β-glucuronide transport in canalicular liver plasma membranes. Hepatology22: 317A.
6.
Meyers M., Slikker W., Pascoe G., and Vore M. (1980). Characterization of cholestasis induced by estradiol 17β-glucuronide in the rat. J. Pharmacol. Exp. Ther. 214: 63-73.
7.
Slikker W., Vore M., Bailey JR, Meyers M., and Montgomery C. (1983). Hepatotoxic effects of estradiol-17β-D-glucuronide in the rat and monkey. J. Pharmacol. Exp. Ther. 225: 138-143.
8.
Vore M. and Hoffman T. (in press). ATP-dependent transport of estradiol-17β-(β-D-glucuronide) in rat canalicular membrane vesicles. Am. J. Physiol.
9.
Vore M. and Slikker W. (1985). Steroid D-ring glucuronides: A new class of cholestatic agents. Trends Pharmacol. Sci. 6: 256-259.
10.
Adams JD, Lauterburg BH, and Mitchell JR (1983). Plasma glutathione and glutathione disulfide in the rat: Regulation and response to oxidative stress. J. Pharmacol. Exp. Ther.227: 749-754. 2.
11.
Akerboom T., Bilzer M., and Sies H. (1982). The relationship of biliary glutathione disulfide efflux and intracellular glutathione disulfide content in perfused rat liver . J. Biol. Chem. 257: 4248-4252.
12.
Bautista AP, Meszaros K., Bojta J., and Spitzer JJ (1990). Superoxide anion generation in the liver during the early stage of endotoxemia in rats. J. Leukoc. Biol. 48: 123-128.
13.
Deleve LD and Kaplowitz N. (1990). Importance and regulation of hepatic glutathione . Semin. Liver Dis. 10: 251-266.
14.
Jaeschke H. (1990). Glutathione disulfide as index of oxidant stress in rat liver during hypoxia. Am. J. Physiol. 258: G499-G505.
15.
Jaeschke H. (1991). Vascular oxidant stress and hepatic ischemia/ reperfusion injury. Free Radic. Res. Commun.12-13: 737-743.
16.
Jaeschke H. (1992). Enhanced sinusoidal glutathione efflux during endotoxin-induced oxidant stress in vivo. Am. J. Physiol. 263: G60-G68.
17.
Jaeschke H. (1995). Mechanisms of oxidant stress-induced acute tissue injury. Proc. Soc. Exp. Biol. Med. 209: 104-111.
18.
Jaeschke H., Bautista AP, Spolarics Z., and Spitzer JJ (1991). Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic. Res. Commun. 15: 277-284.
19.
Jaeschke H. and Benzick EA (1992). Pathophysiological consequences of enhanced intracellular superoxide formation in isolated perfused rat liver . Chem. Biol. Interact. 84: 55-68.
20.
Jaeschke H. and Farhood A. (1991). Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver in vivo. Am. J. Physiol. 260: G355-G362.
21.
Jaeschke H. , Farhood A., Bautista AP, Spolarics Z., Spitzer JJ, and Smith CW (1993). Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology17: 915-923.
22.
Jaeschke H. , Farhood A., and Smith CW (1991). Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am. J. Physiol. 261: G1051-G1056.
23.
Jaeschke H. , Farhood A., and Smith CW (1994). Contribution of complement-stimulated hepatic macrophages and neutrophils to endotoxin-induced liver injury in rats . Hepatology19: 973-979.
24.
Lauterburg BH, Adams JD, and Mitchell JR (1984). Hepatic glutathione homeostasis in the rat: Efflux accounts for glutathione turnover. Hepatology4: 586-590.
25.
Lauterburg BH, Smith CV, Hughes H., and Mitchell JR (1984). Biliary excretion of glutathione and glutathione disulfide in the rat. J. Clin. Invest. 73: 124-133.
26.
Liu P., Fisher MA, Farhood A., Smith CW, and Jaeschke H. (1994). Beneficial effect of extracellular glutathione against reactive oxygen-mediated reperfusion injury in the liver. Circ. Shock43: 64-70.
27.
Liu P., Vonderfecht SL, Fisher MA, McGuire GM, and Jaeschke H. (1994). Priming of phagocytes for reactive oxygen production during hepatic ischemia and reperfusion increases the susceptibilty for endotoxin-induced liver injury. Circ. Shock43: 9-17.
28.
Raiford DS, Smith RM, and Thigpen MC (1994). Nonparenchymal cell-hepatocyte interactions influence hepatic sinusoidal efflux of glutathione. Hepatology20: 179A. (abstract).
29.
Yi JR, Lu S., Fernandez-Checa J., and Kaplowitz N. (1994). Expression cloning of a rat hepatic reduced glutathione transporter with canalicular characteristics. J. Clin. Invest.93: 1841-1845.
30.
Yi JR, Lu S., Fernandez-Checa J., and Kaplowitz N. (1995). Expression cloning of the cDNA for a polypeptide associated with rat hepatic sinusoidal reduced glutathione transport: Characteristics and comparison with the canalicular transporter. Proc. Natl. Acad. Sci. USA 92: 1495-1499.
31.
Cameron GR and Hasan SM (1958). Disturbances of structure and function in the liver as the result of biliary obstruction. J. Pathol. Bacteriol . 75: 333-349.
32.
Cameron G. and Oakley C. (1932). Ligation of the common bile duct. J. Pathol. Bacteriol. 35: 769-798.
33.
Goldstein RS , Meunier PC, and Kossor DC (1994). Relationship of hepatobiliary dysfunction to biliary epithelial cell proliferation following selective bile duct ligation. Toxicologist14(1): 128.
34.
Johnstone JMS and Lee EG (1975). A quantitative assessment of the structural changes in the rat's liver following obstruction of the common bile duct. Br. J. Exp. Pathol. 57: 85-94.
35.
Kossor DC, Goldstein RS, Dulik DM, and Meunier PC (1993). Bile duct obstruction is not a prerequisite for biliary epithelial cell hyperplasia. Toxicologist13(1): 394.
36.
Kossor DC, Goldstein RS, Ngo W., DeNicola DB, Leonard TB, Dulik DM, and Meunier PC (1995). Biliary epithelial cell proliferation following alpha-naphthylisothiocyanate (ANIT) treatment: Relationship to bile duct obstruction . Fundam. Appl. Toxicol. 26: 51-62.
37.
Lopez M. and Mazzanti L. (1955). Experimental investigation on alpha-naphthyliso-thiocyanate as a hyperplastic agent of the biliary ducts in the rat. J. Pathol. Bacteriol. 69: 243-250.
38.
MacDonald RA and Pachet G. (1961). Liver cell regeneration due to biliary obstruction. Arch. Pathol. 72: 133-141.
39.
Slott PA, Liu MH, and Tavoloni N. (1990). Origin, pattern and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology99: 466-477.
40.
Steiner JW, Carruthers JS, and Kalifat SR (1962). The ductular cell reaction of rat liver in extrahepatic cholestasis. I. Proliferated biliary epithelial cells. Exp. Mol. Pathol. 1: 162-185.
41.
Tavoloni N. (1987). The intrahepatic biliary epithelium: An area of growing interest in hepatology. Semin. Liver Dis. 7(4): 280-292.
